Francesca Wuttke Email & Phone Number

Francesca Wuttke Work

• Founder and CEO @ nen (February 2022 - Present)
• Head of Advisory at HLTH @ HLTH Inc. (March 2025 - Present)
• Advisory Board Member @ HLTH Inc. (September 2019 - February 2025)
• Expert Advisor @ EIT Health (November 2024 - Present)
• Industry Advisory Board Member @ Harper Cancer Research Institute (October 2019 - Present)
• Ambassador @ Barcelona Health Hub (June 2019 - Present)
• Chief Digital Officer (CDO) @ Almirall (January 2019 - January 2022)
• Board Member @ Clinithink (September 2018 - January 2019)
• Board Member @ Antidote Technologies (November 2017 - January 2019)
• Managing Director and Investment Principal Europe, Global Health Innovation Fund, LLC @ MSD (March 2016 - January 2019)
• Head of Strategic Market Intelligence and Business Insights- Corporate Development - Licensing and M and A @ Almirall (April 2015 - February 2016)
• Global Director Commercial Strategy, Cell and Gene Therapy Unit @ Novartis (October 2014 - March 2015)
• New Products Director, Cell Therapy @ Novartis (September 2012 - September 2014)
• Global Program Team Director, Critical Care Franchise @ Novartis (November 2011 - August 2012)
• Co-founder and Principal @ Asten BioPharma Advisors, LLC (January 2007 - January 2010)
• Licensing Associate @ Icahn School of Medicine at Mount Sinai (January 2006 - January 2007)
• Associate @ Symphony Capital (January 2002 - January 2006)
• Associate @ Wilkerson Partners (January 2002 - January 2006)
• Clinical Research Coordinator for HIV and AIDS Clinical Trials Unit @ Beth Israel Medical Center, AIDS Clinical Trials Unit (January 1995 - January 1997)